Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction
Background The therapeutic benefit of thrombolytic therapy has been shown to correlate directly with completeness (TIMI grade 3 flow) and speed of reperfusion of the infarct-related coronary artery. The purpose of the RAPID II study was to determine whether a double-bolus regimen of reteplase, a rec...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
1 Sep 1996
|
| In: |
Circulation
Year: 1996, Volume: 94, Issue: 5, Pages: 891-898 |
| ISSN: | 1524-4539 |
| DOI: | 10.1161/01.CIR.94.5.891 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1161/01.CIR.94.5.891 Verlag, lizenzpflichtig, Volltext: https://www.ahajournals.org/doi/10.1161/01.CIR.94.5.891 
|
| Author Notes: | Christoph Bode, Richard W. Smalling, Gunther Berg, Curtis Burnett, Gerald Lorch, John M. Kalbfleisch, Robert Chernoff, Leonard G. Christie, Robert L. Feldman, A. Allen Seals, W. Douglas Weaver |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1886882444 | ||
| 003 | DE-627 | ||
| 005 | 20240703170941.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240424s1996 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1161/01.CIR.94.5.891 |2 doi | |
| 035 | |a (DE-627)1886882444 | ||
| 035 | |a (DE-599)KXP1886882444 | ||
| 035 | |a (OCoLC)1443669222 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Bode, Christoph |e VerfasserIn |0 (DE-588)137596677 |0 (DE-627)594485282 |0 (DE-576)304489611 |4 aut | |
| 245 | 1 | 0 | |a Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction |c Christoph Bode, Richard W. Smalling, Gunther Berg, Curtis Burnett, Gerald Lorch, John M. Kalbfleisch, Robert Chernoff, Leonard G. Christie, Robert L. Feldman, A. Allen Seals, W. Douglas Weaver |
| 264 | 1 | |c 1 Sep 1996 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 24.04.2024 | ||
| 520 | |a Background The therapeutic benefit of thrombolytic therapy has been shown to correlate directly with completeness (TIMI grade 3 flow) and speed of reperfusion of the infarct-related coronary artery. The purpose of the RAPID II study was to determine whether a double-bolus regimen of reteplase, a recently developed deletion mutant of wild-type tissue plasminogen activator, could improve 90-minute coronary artery patency rates achieved with the most successful standard regimen, an “accelerated” front-loaded infusion of alteplase. - - Methods and Results Three hundred twenty-four patients with acute myocardial infarction were randomized to receive (along with intravenous heparin and aspirin) either a 10 plus 10 megaunits double bolus of reteplase or front-loaded alteplase. The primary end point of “patency at 90 minutes, graded according to the TIMI classification” was centrally assessed in a blinded fashion. Infarct-related coronary artery patency (TIMI grade 2 or 3) and complete patency (TIMI grade 3) at 90 minutes after the start of thrombolytic therapy were significantly higher in the reteplase-treated patients (TIMI grade 2 or 3: 83.4% versus 73.3% for front-loaded alteplase-treated patients, P=.03; TIMI grade 3: 59.9% versus 45.2%, P=.01). At 60 minutes, the incidence of both, patency and complete patency, was also significantly higher in reteplase-treated patients (reteplase versus alteplase, TIMI grade 2 or 3: 81.8% versus 66.1%, P=.01; TIMI grade 3: 51.2% versus 37.4%, P<.03). Reteplase-treated patients required fewer acute additional coronary interventions (13.6% versus 26.5%, P<.01), and 35-day mortality was 4.1% for reteplase and 8.4% for alteplase (P=NS). There were no significant differences between reteplase and alteplase in bleedings requiring a transfusion (12.4% versus 9.7%) or hemorrhagic stroke (1.2% versus 1.9%). - - Conclusions Reteplase, when given as a double bolus of 10 plus 10 megaunits to patients with acute myocardial infarction, achieves significantly higher rates of early reperfusion of the infarct-related coronary artery and requires significantly fewer acute coronary interventions than front-loaded alteplase without an apparent increased risk of complications. | ||
| 650 | 4 | |a myocardial infarction | |
| 650 | 4 | |a plasminogen activators | |
| 650 | 4 | |a thrombolysis | |
| 700 | 1 | |a Smalling, Richard W. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Berg, Gunther |e VerfasserIn |4 aut | |
| 700 | 1 | |a Burnett, Curtis |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lorch, Gerald |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kalbfleisch, John M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Chernoff, Robert |e VerfasserIn |4 aut | |
| 700 | 1 | |a Christie, Leonard G. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Feldman, Robert L. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Seals, A. Allen |e VerfasserIn |4 aut | |
| 700 | 1 | |a Weaver, W. Douglas |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Circulation |d Philadelphia, Pa. : Lippincott, Williams & Wilkins, 1950 |g 94(1996), 5, Seite 891-898 |h Online-Ressource |w (DE-627)265784670 |w (DE-600)1466401-X |w (DE-576)074891189 |x 1524-4539 |7 nnas |a Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction |
| 773 | 1 | 8 | |g volume:94 |g year:1996 |g number:5 |g pages:891-898 |g extent:8 |a Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction |
| 856 | 4 | 0 | |u https://doi.org/10.1161/01.CIR.94.5.891 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.ahajournals.org/doi/10.1161/01.CIR.94.5.891 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20240424 | ||
| 993 | |a Article | ||
| 994 | |a 1996 | ||
| 998 | |g 137596677 |a Bode, Christoph |m 137596677:Bode, Christoph |d 910000 |d 910100 |e 910000PB137596677 |e 910100PB137596677 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1886882444 |e 4515830228 | ||
| BIB | |a Y | ||
| SER | |a newspaper | ||
| JSO | |a {"title":[{"title_sort":"Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction","title":"Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction"}],"person":[{"role":"aut","display":"Bode, Christoph","roleDisplay":"VerfasserIn","given":"Christoph","family":"Bode"},{"given":"Richard W.","family":"Smalling","role":"aut","roleDisplay":"VerfasserIn","display":"Smalling, Richard W."},{"given":"Gunther","family":"Berg","role":"aut","display":"Berg, Gunther","roleDisplay":"VerfasserIn"},{"given":"Curtis","family":"Burnett","role":"aut","roleDisplay":"VerfasserIn","display":"Burnett, Curtis"},{"family":"Lorch","given":"Gerald","roleDisplay":"VerfasserIn","display":"Lorch, Gerald","role":"aut"},{"given":"John M.","family":"Kalbfleisch","role":"aut","roleDisplay":"VerfasserIn","display":"Kalbfleisch, John M."},{"roleDisplay":"VerfasserIn","display":"Chernoff, Robert","role":"aut","family":"Chernoff","given":"Robert"},{"given":"Leonard G.","family":"Christie","role":"aut","display":"Christie, Leonard G.","roleDisplay":"VerfasserIn"},{"family":"Feldman","given":"Robert L.","display":"Feldman, Robert L.","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Seals","given":"A. Allen","roleDisplay":"VerfasserIn","display":"Seals, A. Allen","role":"aut"},{"given":"W. Douglas","family":"Weaver","role":"aut","roleDisplay":"VerfasserIn","display":"Weaver, W. Douglas"}],"note":["Gesehen am 24.04.2024"],"type":{"media":"Online-Ressource","bibl":"article-newspaper"},"recId":"1886882444","language":["eng"],"origin":[{"dateIssuedKey":"1996","dateIssuedDisp":"1 Sep 1996"}],"id":{"eki":["1886882444"],"doi":["10.1161/01.CIR.94.5.891"]},"name":{"displayForm":["Christoph Bode, Richard W. Smalling, Gunther Berg, Curtis Burnett, Gerald Lorch, John M. Kalbfleisch, Robert Chernoff, Leonard G. Christie, Robert L. Feldman, A. Allen Seals, W. Douglas Weaver"]},"physDesc":[{"extent":"8 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1524-4539"],"zdb":["1466401-X"],"eki":["265784670"]},"origin":[{"dateIssuedDisp":"1950-","publisher":"Lippincott, Williams & Wilkins ; Ovid","dateIssuedKey":"1950","publisherPlace":"Philadelphia, Pa. ; [Erscheinungsort nicht ermittelbar]"}],"part":{"pages":"891-898","issue":"5","year":"1996","extent":"8","text":"94(1996), 5, Seite 891-898","volume":"94"},"pubHistory":["1.1950 -"],"recId":"265784670","language":["eng"],"corporate":[{"display":"American Heart Association","roleDisplay":"Herausgebendes Organ","role":"isb"}],"type":{"bibl":"newspaper","media":"Online-Ressource"},"note":["Gesehen am 10.10.2025"],"disp":"Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarctionCirculation","title":[{"subtitle":"an official journal of the American Heart Association","title":"Circulation","title_sort":"Circulation"}]}]} | ||
| SRT | |a BODECHRISTRANDOMIZED1199 | ||